Treatment News : HIV-Positive Women May Benefit From HPV Vaccine

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » November 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


November 15, 2012

HIV-Positive Women May Benefit From HPV Vaccine

HIV-positive women may benefit from the human papillomavirus (HPV) vaccine, especially the more than 45 percent of sexually active young women who have not been exposed to the higher-risk forms of HPV, according to a new study from the National Institutes of Health, published in the Journal of Acquired Immune Deficiency Syndromes. As reported in Genetic Engineering & Biotechnology News, the study concluded that even among women who have tested positive for one form of HPV, the vaccine may still prevent other forms that can cause cancer.

After giving 99 HIV-positive women between 16 and 23 years old an initial HPV vaccine, the study’s authors tested them for 41 of the over 100 types of HPV. They found that 75 percent of the study participants had at least one form of HPV infection and that 54 percent had a high-risk type. However, among the two forms of HPV that cause 70 percent of cervical cancers, HPV-16 and HPV-18, only a respective 12 and 5 percent of the study group had an existing infection or showed signs of exposure. Because HIV can make women more likely to develop cervical cancer or other hard-to-treat cancers as a result of these two types of HPV, the study’s authors recommend HPV vaccines for HIV-positive women, as well as cervical cancer screening.

To read the Genetic Engineering & Biotechnology News article, click here.

To read the NIH release, click here.

Search: HIV, HPV, human papillomavirus, vaccine, sexually active, women, National Institutes of Health, Journal of Acquired Immune Deficiency Syndromes, Genetic Engineering & Biotechnology News, cancer, high-risk, strains.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.